Barriers to accessing treatment for substance use after inpatient managed withdrawal (Detox): A qualitative study

被引:8
|
作者
David, Allison R. [1 ]
Sian, Carlos R. [2 ]
Gebel, Christina M.
Linas, Benjamin P. [2 ,3 ,4 ]
Samet, Jeffrey H. [1 ]
Martinez, Linda S. Sprague [5 ]
Muroff, Jordana [5 ]
Bernstein, Judith A.
Assoumou, Sabrina A. [2 ,3 ,4 ]
机构
[1] Boston Med Ctr, Dept Med, 72 East Concord St,Evans 124, Boston, MA 02118 USA
[2] Boston Med Ctr, Crosstown Ctr, Sect Infect Dis, 801 Massachusetts Ave,2nd Floor, Boston, MA 02118 USA
[3] Boston Univ, Sch Publ Hlth, Crosstown Ctr, 801 Massachusetts Ave, Boston, MA 02118 USA
[4] Boston Univ, Sch Med, Crosstown Ctr, 801 Massachusetts Ave,2nd Floor, Boston, MA 02118 USA
[5] Boston Univ, Sch Social Work, 264 Bay State Rd, Boston, MA 02215 USA
关键词
Drug detoxification center; People who inject drugs; Continuity of care; Linkage to care; Access to care; Medications for opioid use disorder; OPIATE DETOXIFICATION; USE DISORDERS; FOLLOW-UP; ADHERENCE;
D O I
10.1016/j.jsat.2022.108870
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Introduction: Access to and uptake of evidence-based treatment for substance use disorder, specifically opioid use disorder (OUD), are limited despite the high death toll from drug overdose in the United States in recent years. Patient perceived barriers to evidence-based treatment after completion of short-term inpatient medically managed withdrawal programs (detox) have not been well studied. The purpose of the current study is to elicit patients' perspectives on challenges to transition to treatment, including medications for OUD (MOUD), after detox and potential solutions. Methods: We conducted semi-structured interviews (N = 24) at a detox center (2018-2019) to explore patients' perspectives on obstacles to treatment. The study managed the data in NVivo and we used content analysis to identify themes. Results: Patients' characteristics included the following: 54 % male; mean age 37 years; self-identified as White 67 %, Black 13 %, Latinx 8 %, Native Hawaiian/Pacific Islander 4 %, and other 8 %; heroin use in the past 3 months 67 %; and ever injecting drugs 71 %. Patients identified the following barriers: 1) lack of continuity of care; 2) limited number of detox and residential treatment program beds; 3) unstable housing; and 4) lack of options when choosing a treatment pathway. Solutions proposed by participants included: 1) increase low -barrier access to community MOUD; 2) add case managers at the detox center to establish continuity of care after discharge; 3) increase assistance with housing; and 4) encourage patient participation in treatment decisions. Conclusions: Patients identified lack of continuity of care, especially care coordination, as a major barrier to substance use treatment. Increasing treatment utilization, including MOUD, necessitates a multimodal approach to continuity of care, low-barrier access to MOUD, and support to address unstable housing. Patients want care that incorporates options and respect for. individualized preferences and needs.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Barriers and Facilitators to Substance Use Treatment in the Rural South: A Qualitative Study
    Browne, Teri
    Priester, Mary Ann
    Clone, Stephanie
    Iachini, Aidyn
    DeHart, Dana
    Hock, Robert
    JOURNAL OF RURAL HEALTH, 2016, 32 (01) : 92 - 101
  • [2] Systemic barriers accessing HIV treatment among people who inject drugs in Russia: a qualitative study
    Sarang, Anya
    Rhodes, Tim
    Sheon, Nicolas
    HEALTH POLICY AND PLANNING, 2013, 28 (07) : 681 - 691
  • [3] Relapse after inpatient substance use treatment: A prospective cohort study among users of illicit substances
    Andersson, Helle Wessel
    Wenaas, Merethe
    Nordfjaern, Trond
    ADDICTIVE BEHAVIORS, 2019, 90 : 222 - 228
  • [4] Mental distress following inpatient substance use treatment, modified by substance use; comparing voluntary and compulsory admissions
    Pasareanu, Adrian R.
    Vederhus, John-Kare
    Opsal, Anne
    Kristensen, Oistein
    Clausen, Thomas
    BMC HEALTH SERVICES RESEARCH, 2017, 17 : 1 - 9
  • [5] Initiation of oral hepatitis C virus treatment: Which barriers are pertinent for ambulatory individuals with a history of illicit substance use? A qualitative interview study
    Barbati, Selina
    Strasser, Johannes
    Allemann, Samuel S.
    Arnet, Isabelle
    HEALTH SCIENCE REPORTS, 2024, 7 (01)
  • [6] A qualitative study of barriers to and facilitators of optimal engagement in care among PLWH and substance use/misuse
    Kuchinad K.E.
    Hutton H.E.
    Monroe A.K.
    Anderson G.
    Moore R.D.
    Chander G.
    BMC Research Notes, 9 (1)
  • [7] Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment: A Prospective Study
    Davis, Jordan P.
    Smith, Douglas C.
    Morphew, Jason W.
    Lei, Xinrong
    Zhang, Saijun
    JOURNAL OF DRUG ISSUES, 2016, 46 (01) : 64 - 83
  • [8] Barriers to guideline-concordant antibiotic use among inpatient physicians: A case vignette qualitative study
    Livorsi, Daniel
    Comer, Amber R.
    Matthias, Marianne S.
    Perencevich, Eli N.
    Bair, Matthew J.
    JOURNAL OF HOSPITAL MEDICINE, 2016, 11 (03) : 174 - 180
  • [9] Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators
    O'Grady, Megan A.
    Elkington, Katherine S.
    Robson, Gail
    Achebe, Ikenna Y.
    Williams, Arthur Robin
    Cohall, Alwyn T.
    Cohall, Renee
    Christofferson, Monica
    Garcia, Alejandra
    Ramsey, Kelly S.
    Lincourt, Pat
    Tross, Susan
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2024, 19 (01)
  • [10] Referral to and engagement in substance use disorder treatment within opioid intervention courts in New York: a qualitative study of implementation barriers and facilitators
    Megan A. O’Grady
    Katherine S. Elkington
    Gail Robson
    Ikenna Y. Achebe
    Arthur Robin Williams
    Alwyn T. Cohall
    Renee Cohall
    Monica Christofferson
    Alejandra Garcia
    Kelly S. Ramsey
    Pat Lincourt
    Susan Tross
    Substance Abuse Treatment, Prevention, and Policy, 19